Prezzo di chiusura
Altri mercati azionari
|
||
- USD | - |
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Matthew Pauls
CEO | Chief Executive Officer | 53 | 27/04/17 |
David Lowrance
DFI | Director of Finance/CFO | 56 | 27/04/17 |
Robert M. Lutz
COO | Chief Operating Officer | 55 | 13/02/23 |
Raymond Pratt
CTO | Chief Tech/Sci/R&D Officer | 73 | 10/11/22 |
Anne Erickson
IRC | Investor Relations Contact | - | 01/10/18 |
Charles LaPree
LAW | General Counsel | - | 01/08/21 |
Kate McCabe
LAW | General Counsel | - | 01/03/18 |
Scott Wilhoit
PRN | Corporate Officer/Principal | 61 | 09/01/23 |
Peter M. Clarke
PRN | Corporate Officer/Principal | 64 | 01/09/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
David Ramsay
BRD | Director/Board Member | 59 | 27/04/17 |
Richard Hawkins
BRD | Director/Board Member | 75 | 01/10/10 |
Nevan Elam
BRD | Director/Board Member | 56 | 01/02/09 |
Ricky Sun
BRD | Director/Board Member | 50 | 24/12/19 |
Joseph McCracken
BRD | Director/Board Member | 71 | 27/04/17 |
Matthew Pauls
CEO | Chief Executive Officer | 53 | 27/04/17 |
Director/Board Member | 64 | 03/12/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 138 188 891 | 130 399 382 ( 94,36 %) | 0 | 94,36 % |
Coordinate società
Savara, Inc.
1717 Langhorne Newtown Road Suite 302
19047, Langhorne
+(512) 614-1848
http://www.savarapharma.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+3,91% | 109 Mrd | |
+10,87% | 105 Mrd | |
+1,28% | 22,25 Mrd | |
-13,14% | 22,09 Mrd | |
-7,05% | 18,68 Mrd | |
-38,36% | 17,58 Mrd | |
-10,66% | 16,85 Mrd | |
+3,75% | 13,76 Mrd | |
+36,70% | 12,46 Mrd |
- Borsa valori
- Azioni
- Azione SVRA
- Azione
- Società Savara Inc